Changes in plasma renin activity after administration of spironolactone.
D000293:Adolescent; D000328:Adult; D001017:Aortic Coarctation / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects; D003480:Cushing Syndrome / Q000097:blood; D005260:Female; D005921:Glomerulonephritis / Q000097:blood; D006801:Humans; D006929:Hyperaldosteronism / Q000097:blood*; D006973:Hypertension / Q000097:blood*; D006977:Hypertension, Renal / Q000097:blood; D007674:Kidney Diseases / Q000097:blood; D008297:Male; D008875:Middle Aged; D010673:Pheochromocytoma / Q000097:blood; D011188:Potassium / Q000097:blood; D012083:Renin / Q000097:blood*; D012964:Sodium / Q000097:blood; D013148:Spironolactone / Q000494:pharmacology*
D013148:Spironolactone; D012964:Sodium; D012083:Renin; D011188:Potassium